Search hospitals > Wisconsin > Sturgeon Bay

Saint Vincent Hospital Cancer Center at Sturgeon Bay

Claim this profile
Sturgeon Bay, Wisconsin 54235
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Tumors
137 reported clinical trials
4 medical researchers
Photo of Saint Vincent Hospital Cancer Center at Sturgeon Bay in Sturgeon BayPhoto of Saint Vincent Hospital Cancer Center at Sturgeon Bay in Sturgeon BayPhoto of Saint Vincent Hospital Cancer Center at Sturgeon Bay in Sturgeon Bay

Summary

Saint Vincent Hospital Cancer Center at Sturgeon Bay is a medical facility located in Sturgeon Bay, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Tumors and other specialties. Saint Vincent Hospital Cancer Center at Sturgeon Bay is involved with conducting 137 clinical trials across 332 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Catherine A. Long, and Anthony J. Jaslowski.

Area of expertise

1Cancer
Global Leader
Saint Vincent Hospital Cancer Center at Sturgeon Bay has run 62 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Breast Cancer
Global Leader
Saint Vincent Hospital Cancer Center at Sturgeon Bay has run 29 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Saint Vincent Hospital Cancer Center at Sturgeon Bay

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Oropharyngeal Carcinoma
Squamous Cell Carcinoma
Tumors
Prostate Cancer
Recurrence
Ovarian Tumors
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Saint Vincent Hospital Cancer Center at Sturgeon Bay?
Saint Vincent Hospital Cancer Center at Sturgeon Bay is a medical facility located in Sturgeon Bay, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Tumors and other specialties. Saint Vincent Hospital Cancer Center at Sturgeon Bay is involved with conducting 137 clinical trials across 332 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Catherine A. Long, and Anthony J. Jaslowski.